Free Trial

Alvotech (ALVOW) Competitors

Alvotech logo
$3.16 -0.04 (-1.25%)
As of 01/17/2025 03:56 PM Eastern

ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, ACABW, BFRIW, BTMDW, BCTXW, CELUW, and CINGW

Should you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry.

Alvotech vs.

Alvotech (NASDAQ:ALVOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$391.87MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Alvotech Neutral
180 Life Sciences Neutral

Alvotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
AlvotechN/AN/A
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Alvotech beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVOW vs. The Competition

MetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.17B$5.21B$9.14B
Dividend YieldN/A3.04%5.13%4.02%
P/E RatioN/A130.9089.3417.36
Price / SalesN/A2,866.551,240.0477.11
Price / CashN/A10.2543.7535.97
Price / BookN/A3.225.314.79
Net IncomeN/A$152.21M$122.54M$225.00M
7 Day Performance3.27%-0.24%0.59%2.62%
1 Month Performance6.40%3.34%2.55%3.81%
1 Year Performance-4.24%101.86%25.29%20.10%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVOW
Alvotech
N/A$3.16
-1.3%
N/A-4.2%$0.00$391.87M0.004News Coverage
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+9.7%
N/A+73.1%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
-7.3%
N/A+3.8%$0.00N/A0.002
AIMDW
Ainos
N/A$0.19
+11.8%
N/AN/A$0.00$40,633.000.0040
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
-23.5%
N/AN/A$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.09
+1.4%
N/AN/A$0.00$35.36M0.0070
BTMDW
biote
N/A$0.41
-16.3%
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.17
+3.8%
N/A-92.7%$0.00N/A0.008Short Interest ↑
CELUW
Celularity
N/A$0.03
-1.8%
N/AN/A$0.00$48.20M0.00220
CINGW
Cingulate
N/A$0.08
-5.7%
N/AN/A$0.00N/A0.0020Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:ALVOW) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners